WJMI, 5(1), 2025 - WORLD JOURNAL OF MEDICAL INNOVATIONS | A ailable a www.wo ldjmi.com
32
Resul s o Fa -UVC and P o ec i e Tex ile Based Sys em o Ge m
F ee Angiog aphy Uni s
Ayhan Olcay1, Se da Baki Albay ak1, Ib ahim Fa uk Ak u k2, Onu Yolay1,3, Veda Oz u k4, Ozgu
Yasa 5, Mehme Ka abay6, He man Mayisoglu7, Mus a a Mazlum8, Mehme Ce in Baye 8, Ceyhun
Hazi oglu9, Fadil Umihanić10
1. R&D Depa men , Innoway R&D K ., Budapes , Hunga y.
2. Baki köy Sadi Konuk Educa ion and Resea ch Hospi al, İs anbul, Tu key.
3. Boğaziçi Uni e si y Cen e o Ta ge ed The apy Technologies, İs anbul, Tu key.
4. İs anbul Aydin Uni e si y, Depa men o Mechanical Enginee ing, İs anbul, Tu key.
5. Medicana Bahçelie le Hospi al, Depa men o Oph halmology, İs anbul, Tu key.
6. Medicana Bahçelie le Hospi al, In ec ious Diseases Depa men , İs anbul, Tu key.
7. Medicana Bahçelie le Hospi al, Depa men o De ma ology, İs anbul, Tu key.
8. Ves el Home Appliances Resea ch and De elopmen Depa men , Manisa, Tu key.
9. School o Medicine, Ma ma a Uni e si y, Is anbul, Tu key.
10. Is anbul Uni e si y Ce ahpasa School o Medicine, Is anbul, Tu key.
A icle in o
Abs ac
PUBLIC HEALTH
NEUROSURGERY
O iginal s udy
A icle his o y:
Accep ed
Oc obe 01, 2025
Published online
Oc obe 12, 2025
Copy igh © 2025 by
WJMI All igh s
ese ed
Me hods: A p e-pos s udy design was implen ed a Bahçelie le Medicana Hospi al
du ing he peak o he Co id-19 pandemic, om Feb ua y 11, 2021, o Ma ch 5, 2021. The
s udy popula ion consis ed o 11 indi iduals diagnosed wi h co ona y a e y disease and 4
heal hca e p o essionals wi hou any diagnosed medical condi ions. Among he 11
pa ien s, 10 unde wen co ona y angiog aphy, 1 unde wen co ona y s en ing, and 1
unde wen pe iphe al angiog aphy. The angiog aphy sui e was equipped wi h he Ini us-
V Fa -UVC sys em, and all p ocedu es we e conduc ed unde his sys em. Skin e y hema,
ocula condi ion, and in ec ion s a us we e assessed p io o and immedia ely ollowing
exposu e, wi h ollow-up e alua ions conduc ed 24 hou s and 1 week la e . Resul s: The
a e age age o pa ien s was 48 yea s, wi h a s anda d de ia ion o 7.35 yea s. Con e sely,
he a e age age o heal hca e pe sonnel was eco ded a 36.75 yea s, wi h a s anda d
de ia ion o 9.53 yea s. No ably, one pa ien es ed posi i e o Co id-19 bo h p io o and
a e he p ocedu e. In con as , no heal hca e pe sonnel we e ound o be posi i e o
Co id-19 in ec ion a any poin , ei he be o e o a e he p ocedu es we e conduc ed. The
ex ile clo hing u ilized in he Ini us-V sys em is cha ac e ized by an Ul a iole P o ec ion
Fac o (UPF) ha e ec i ely il e s ou 98% o Fa -UVC adia ion, pe mi ing only 2% o
pene a e, he eby signi ican ly educing he isk o UVC exposu e. Mo eo e , no
disce nible changes o he skin o eyes o any pa icipan s we e a ibu able o exposu e
o 222nm UVC du ing o ollowing he p ocedu es. Conclusion: The Fa -UVC sys em
p o ides e ec i e ge micidal ac ion wi hou p esen ing isks in ope a ing ooms, o e ing
p omising po en ial o a b oad ange o applica ions, including public anspo a ion and
hospi al ooms. The implemen a ion o his echnology, coupled wi h Fa -UVC- esis an
ex iles, may educe he eliance on adi ional epidemiological measu es, which can ha e
signi ican global economic and social impac s. Fu he mo e, his sys em o e s a p oac i e
solu ion o p e en ing he ansmission o ae osolized pa hogens, bypassing he delays
associa ed wi h ex ensi e human ials o complex egula o y p ocesses.
Co esponding au ho . P o . D . Ayhan Olcay, R&D Depa men , Innoway R&D K .,
Budapes , Hunga y, e-mail: olcay@innoway d.hu
Keywo ds:
COVID-19,
Fa -UVC,
Ul a iole Ge micidal
I adia ion,
public heal h
WJMI, 5(1), 2025 - WORLD JOURNAL OF MEDICAL INNOVATIONS | A ailable a www.wo ldjmi.com
33
In oduc ion.
Co ona i us disease 2019 (COVID-19) was i s
iden i ied in Decembe 2019 and decla ed a pandemic
on Ma ch 11, 2020. Despi e ex ensi e e o s o con ain
he disease, COVID-19 has esul ed in 753 million
con i med cases and o e 6.8 million dea hs as o
Janua y 30, 2023, (1). The apid inc ease in cases,
leading o se e e pulmona y and ex apulmona y
mani es a ions, b inging some heal hca e sys ems o
he b ink o collapse (2-7). COVID-19 is belie ed o be
ansmi ed h ough bo h di ec con ac and ai bo ne
ou es (8). Thus, he implemen a ion o inno a i e
echnologies is c i ical o p e en ing he sp ead o he
disease in hospi als and public a eas. This necessi y is
unde sco ed by he i us's abili y o emain iable in
ae osols o up o h ee hou s and he po en ial o
ansmission om asymp oma ic ca ie s (2).
Fu he mo e, lockdowns and social dis ancing
measu es ha e signi ican ly dis up ed he global
economy, wi h p onounced e ec s in egions
cha ac e ized by subs an ial income inequali y (9).
Ul a iole ge micidal i adia ion (UVGI) is de ined as
he use o ul a iole (UV) ligh in he ge micidal ange
(wa eleng hs: 200–320 nm) o he disin ec ion o ai
and su aces I is a p o en me hod cu en ly employed
in high- isk se ings (10), (11-13). Ul a iole -C (UVC)
adia ion is he mos e ec i e and commonly used
ge micidal wa eleng h ange o he ul a iole
spec um (11). UVC ligh induces he o ma ion o
pho op oduc s, such as py imidine dime s, which
cause s uc u al dis o ions in DNA and dis up
RNA/DNA ansc ip ion and eplica ion p ocesses,
e ec i ely killing a ious mic oo ganisms in di e en
se ings (12-15). In ac , UVGI was e ec i ely used in
ube culosis wa ds in he pas bu has esu aced as a
popula choice du ing Co id-19 pandemic (16, 17). A
low-p essu e me cu y- apo a c lamp emi ing abou
254 nm is he mos o en u ilized o m o UV ligh o
an imic obial pu poses; howe e , xenon lamp
echnology has also been used, which p o ides a b oad
UV spec um. (3-5) These can be used o ai
disin ec ion ei he as duc i adia ion o uppe oom
UVGI (UV ligh p ojec ion in a oom abo e people’s
heads). These UV ligh s canno be used in he p esence
o li ing o ganisms due o he isk o se ious skin and
eye p oblems (6, 7, 9, 10).
Fa -UVC (207 o 222 nm) ep esen s an ad anced o m
o UVC ha is as e ec i e a elimina ing
mic oo ganisms as con en ional ge micidal UV ligh
(18). Recen s udies ha e demons a ed ha Fa -UVC
exposu e does no cause he skin and eye p oblems
associa ed wi h con en ional UVC exposu e (18-21).
Fa -UVC ligh can pene a e only a ew mic ome e s,
which is su icien o inac i a e i uses and bac e ia in
biological ma e ials as well as in he s a um co neum
o he skin. I does no pene a e he s a um co neum
o he ocula ea laye , hus no eaching li ing human
cells in he skin o eyes. Thus, Fa -UVC p o ides he
same ge micidal e icacy as con en ional UVC bu
wi hou he associa ed heal h haza ds (18-21). Fa -UVC
ligh (207 o 222 nm) is p oduced by low-cos excime
lamps and has he po en ial o be used in c owded
public loca ions (18, 22-24). Low-dose- a e Fa -UVC
can be an e ec i e me hod o p e en ing ae osolized
i us ansmission in public a eas (23).
Cu en ly, he e a e no ope a ing ooms, in ensi e ca e
uni s, o s e ile se ings u ilizing UVC lamps wi h
wa eleng hs o 200-222 nm.
Objec i es
To e alua e he e ec s o he Ini us-V Fa -UVC sys em
on he skin and eyes o indi iduals wea ing sa e y
goggles and UVC-p o ec i e ponchos o o e alls, as
well as he ansmission o in ec ion o heal hca e
wo ke s in hospi al se ings.
Me hods
The s udy is a p e-pos design. The s udy was
conduc ed in a single cen e a Bahçelie le Medicana
Hospi al du ing peak Co id-19 pandemic om
11.02.2021 o 05.03.2021. E hical commi ee
pe missions we e ecei ed and all pa ien s we e
insu ed o ials. 11 indi iduals wi h co ona y a e y
disease and 4 heal hca e wo ke s wi h no diagnosed
condi ion olun ee ed o pa icipa e in he s udy.
Pa icipan s signed an in o med consen o m. The
pa icipan s' ages ange om 25 o 75. Males made up
11 (73%) o he o al pa icipan s, while emales made
WJMI, 5(1), 2025 - WORLD JOURNAL OF MEDICAL INNOVATIONS | A ailable a www.wo ldjmi.com
34
up 4 (27%). The exclusion c i e ia we e: (i) skin
diso de s o skin- ela ed malignancies, (ii) ecen eye
su ge y, (iii) co neal and e inal abno mali ies, (i )
glaucoma.
P ocedu e
Ini us-V Sys em Desc ip ion and 222nm UVC ligh
sou ce.
Ini us-V sys em was de eloped collabo a i ely by
InnowayRG Inc and Ves el Home appliances Inc. A
pa en applica ion has been made o TURKPATENT in
he pa ne ship o hese wo companies
(TR2020/07546). This app oach allows o he ins an
deploymen o Fa -UVC echnology wi hou any
egula o y au ho i y con lic o es ic ion. The 222nm
ligh sou ce o Ini us-V was p oduced by Ves el Inc.
(Manisa, Tu key) and InnowayRG Inc. (Is anbul, Tu key)
ea u es a k yp on-chlo ide (K -Cl) excime lamp and
an op ical il e wi h a maximum ou pu wa eleng h o
222nm and emission wa eleng hs anging om 200 o
230nm.
The uni consis s o a lamp, ai cooling an, mi o s and
a specialized band-pass il e . The a ached il e
e ec i ely elimina es almos all wa eleng hs ou side
he dominan 222nm emission. The in ensi y o 222nm
ligh was measu ed wi h an S-172 / UIT250
accumula ed UV me e (Ushio Inc.) and was ound o
be maximum 2.23 uW/cm2 a he cen e and minimum
1.34 uW/cm2 a he dis ance o 2.5 me e s (Figu e 1).
Figu e 1. Ini us-V’s 222 nm Fa -UVC ligh sou ce p oduced by Ves el and InnowayRg Inc. The maximum pe missible 222nm UVC
adia ion limi
The limi o hose exposed o 222nm UVC in an 8-hou
pe iod de e mined by he In e na ional Commission on
Non-ionizing Radia ion P o ec ion (ICNIRP) is
app oxima ely 22 mJ/cm2 (25). ACGIH, he Ame ican
Associa ion o Indus ial Hygienis s o he U.S.
go e nmen , ecen ly eleased an upda ed documen
and he daily i adia ion limi o 222 nm was inc eased
om 22 mJ/cm2 o 160 mJ/cm2 (eye co neal
i adia ion) and 478 mJ/cm2 (skin i adia ion), which
expands applica ion o Fa -UVC echnology p oduc s
(26).
Tex ile ab ic used in Ini us-V sys em and UVC 222nm
ansmi ance measu emen s.
The ansmi ance o he 222 nm wa eleng h h ough
he ex ile clo hing (o e alls) used in he Ini us-V
sys em was measu ed using a Me le Toledo UV7
spec opho ome e . The esul s showed an a e age
ansmi ance o 1.5%. Addi ionally, he ex ile clo hing
used in he Ini us-V sys em possesses an Ul a iole
P o ec ion Fac o (UPF) o 50+, which quan i ies he
ab ic's abili y o block UV adia ion, including bo h
UVB and UVA ays. A UPF 50 ab ic il e s ou 98% o
UV adia ion, allowing only 2% (1/50 h) o pass
h ough, hus signi ican ly minimizing he isk o UV
exposu e (Figu e 2).
WJMI, 5(1), 2025 - WORLD JOURNAL OF MEDICAL INNOVATIONS | A ailable a www.wo ldjmi.com
35
Figu e 2. Ini us-V ex ile ab ic o e all 222nm wa eleng h ansmi ance measu emen s by Me le Toledo UV7
spec opho ome e .
Ini us-V 222nm UVC sou ce ins alla ion in he wo king
en i onmen and UVC exposu e calcula ion.
To ensu e ha he UVC exposu e o a 170 cm all
ope a o emains wi hin legal limi s while wea ing
ab ic o e alls, Ini us-V UVC sou ces should be
posi ioned a leas 220 cm abo e he g ound.
Measu emen s indica e ha his se up keeps exposu e
wi hin he daily pe mi ed limi o 22 mJ/cm²,
conside ing 1.5% ab ic pe meabili y o he head a ea.
This means ha unde he ab ic, he UVC exposu e will
be 22 mJ/cm² o e an 8-hou pe iod, while he su ace
o he ab ic will expe ience 1488 mJ/cm². These alues
a e achie ed a 50 cm om he Ini us-V UVC sou ce.
The e o e, he de ices mus be placed mo e han 50
cm away om he ope a o 's nea es body pa .
Ope a ing Room/In ensi e Ca e Sys em wi h ac i e
Ini us-V Fa -UVC ligh se up sa e o pe sonnel o wo k
in:
The Ini us-V sys em u ilizes a 200-222nm UVC ligh
sou ce in conjunc ion wi h UVC-p oo glasses and
p o ec i e ex ile clo hing while UVC is ac i e in he
en i onmen . Despi e se e al s udies con i ming he
sa e y o Fa -UVC ligh on skin and eyes in animal ials,
we op ed o inco po a e ex ile and goggle p o ec ion
o comply wi h ICNIRP's exis ing egula o y limi s. Wi h
he lack o long- e m human ials wi h a -UVC
echnology, egula o y o ganiza ions a e highly
hesi an o allow i s usage in he p esence o li ing
indi iduals.
WJMI, 5(1), 2025 - WORLD JOURNAL OF MEDICAL INNOVATIONS | A ailable a www.wo ldjmi.com
36
Du ing ials ope a ing ooms, in ensi e ca e uni s,
eme gency ooms o o he s e ile a eas we e
illumina ed wi h ixed o mo able Ini us-V UVC ligh
sou ces emi ing ligh in he 200-222 nm wa eleng h o
p e en su gical ield in ec ion (Figu e 3). Du ing
p ocedu es, ope a o s and auxilia y s a wo e UVC-
p o ec i e o e alls and UVC-p o ec ing goggles. The
inno a i e ex ile ensu es ha human exposu e o 222
nm UVC i adia ion emains below egula o y limi s,
acili a ing he use o Fa -UVC in all condi ions wi hou
he need o ex ensi e human ials.
Figu e 3. The ope a ing ooms equi ing s e ili y a e illumina ed wi h ixed Ini us-V UVC ligh sou ces ha emi ligh wi hin he
200-222 nm wa eleng h ange. Addi ionally, mo able UVC lamps a e u ilized o p e en su gical ield in ec ion.
UVC-p o ec i e o e alls a e a ailable in designs ha
co e he en i e body and head, ei he wi h a on
zippe o as a poncho o ease o mo emen and
com o .
Pa ien s in he in ensi e ca e uni o ope a ing oom
we e shielded wi h UVC p o ec i e co e s (Figu e 4,5)
and, i necessa y, addi ional UVC p o ec i e eyewea .
WJMI, 5(1), 2025 - WORLD JOURNAL OF MEDICAL INNOVATIONS | A ailable a www.wo ldjmi.com
37
Figu e 4. Ope a o s and o he auxilia y pe sonnel wo e UVC-p o ec i e o e alls designed o co e he whole body and zippe ed
in he on o as poncho o easie mo emen and com o .
Figu e 5. Angiog aphy sui was illumina ed wi h Ini us-V UVC ligh sou ce o exposu e measu emen s p io o ini ia ing pa ien
clinical s udies.
WJMI, 5(1), 2025 - WORLD JOURNAL OF MEDICAL INNOVATIONS | A ailable a www.wo ldjmi.com
38
Resul s
Pa ien s we e olde (48 ± 7.35) han heal hca e
pe sonnel (36.75 ± 9.53) yea s. One pa ien was COVID-
19 posi i e bo h p e- and pos -p ocedu e. Heal hca e
pe sonnel we e no posi i e o Co id-19 in ec ion
nei he be o e no a e he su ge y. The a e age o
o al 222nm UVC exposu e ime was much sho e
(23.2 ± 10 minu es) o pa ien s han i was o
heal hca e wo ke s (277.5 ± 18.93 minu es). The e
we e no obse ed skin o eye changes due o 222nm
UVC exposu e in any pa icipan s. Follow-up ques ions
conce ning skin and ocula condi ions we e no mal 24
hou s and 1 week a e he p ocedu e.
Discussion
A se ious ise in Heal h Ca e Associa ed In ec ions
(HCAI) has d ama ically inc eased heal hca e cos s. In
2000, HCAIs caused 5,000 dea hs in he Uni ed
Kingdom (UK) alone, causing a 1% inc ease in he o al
UK Na ional Hospi al budge (27). The US Cen e s o
Disease Con ol and P e en ion es ima ed he o al
cos s in No h Ame ica o be in excess o $6 billion
($US) o ea ing HCAIs and hei associa ed
complica ions (28). I is es ima ed ha app oxima ely
2.4 billion € a e spen annually o ea men o HCAIs
in Ge many (29).
In asi e angiog aphy sui p ocedu es a e also mo al
and cos ly. Pacemake implan a ions a e equen ly
pe o med pe manen endoca dial leads implan a ion
in ec ion a e is be ween 1% and 2%, bu he e a e
li e a u es epo ing 0.13% o 12.6% a es. Implan able
an i a hy hmic sys em numbe s a e inc easing, and
he Na ional Hospi al Discha ge Su ey e ealed ha
be ween 1996 and 2003, he a es o hospi aliza ion
o in ec ions o implan able an ia hy hmic sys ems
inc eased as e han he a es o sys em implan a ions
(30).
TAVI is now ou inely pe o med in angiog aphy sui s
and TAVI ela ed in ec i e endoca di is is mo al and
seen in 3.25% o cases. The mos common
complica ion is hea ailu e wi h a cumula i e
incidence o 37.1%. En e ococci a e he mos common
causa i e o ganism isola ed om 25.9% o cases
ollowed by S aphylococcus au eus in 16.1% o cases.
App op ia e s e ili y measu es and an ibio ic
p ophylaxis a e s anda d p ocedu es (31).
Endo ascula aneu ysm epai s (EVAR) a e also
ou inely pe o med in angiog aphy sui s and
p os hesis in ec ion a es a e be ween 0.2% and 5%
(32). Fa -UVC echnology has he po en ial o become
s anda d angiog aphy sui equipmen o educe
implan able de ice in ec ion a ed as highe isk
pa ien s and p ocedu es a e p og essi ely inc easing in
ca diology.
T ansmission o Fa -UVC ligh a 200 nm om he
co nea o he lens is p edic ed o be essen ially ze o. I
has been obse ed ha 207 nm UV ligh e ec i ely kills
MRSA, wi hou causing signi ican damage o human
cells, unlike con en ional ge micidal UV lamps (18-21).
Fu he mo e, esea ch in ol ing Xpa knockou mice
and wild- ype mice subjec ed o epe i i e 222 nm UVC
i adia ion, ollowing a umo -inducing p o ocol ha
p oduces umo s wi h b oad-band UVB, showed no
e idence o umo induc ion (22).
Con a y o signi ican side e ec s obse ed wi h
adi ional ge micidal UV lamps, Resea ch using a
h ee-dimensional human skin model has shown ha
exposu e o 207 nm UV ligh esul s in i ually no
mu agenic UV-associa ed DNA lesions (18, 24). This
sugges s ha Fa -UVC s e iliza ion can be sa ely
conduc ed in en i onmen s wi h human p esence.
In a p e ious s udy, he e ec s o skin exposu e o 222
nm UV adia ion we e e alua ed using a de ice
designed o s e ilize equipmen (S e il ay™ Heal h
En i onmen Inno a ions, Do e , New Hampshi e,
USA). The s udy assessed he induc ion o skin
e y hema and cyclobu ane py imidine dime s (CPD) in
skin biopsies. Findings indica ed ha he UVC-emi ing
S e il ay no only induced e y hema bu also caused
DNA damage in he o m o CPDs, which a e associa ed
wi h skin cance . These e ec s we e obse ed a
dosage le els below he h eshold o bac e ios a ic o
bac e icidal e ec s. This sugges s ha equen ,
se e al- imes-daily use o S e il ay i adia ion is
unlikely o be ole a ed as a non-chemical an isep ic o
human skin (33).
A ecen pape e ealed ha iable SARS-CoV-2 can be
p esen in ae osols gene a ed by a Co id-19 pa ien in
a hospi al oom in he absence o an ae osol-
WJMI, 5(1), 2025 - WORLD JOURNAL OF MEDICAL INNOVATIONS | A ailable a www.wo ldjmi.com
39
gene a ing p ocedu e and can hus se e as a sou ce
o ansmission o he i us in his se ing (34). Ai
samples we e collec ed in a oom wi hin a designa ed
Co id-19 wa d, which had six ai changes pe hou . The
exhaus ai unde wen iple il e ea men , coil
condensa ion o emo e mois u e, and UV-C
i adia ion be o e 90% o he ea ed ai was ecycled
back in o he oom. The ai -sample s we e s a ioned
om 2 o 4.8 m away om he pa ien s. This a icle
sugges s ha despi e maximum ai il e ing, ae osol
ansmission is possible om a 4.8-me e dis ance
om a pa ien . The Ini us-V sys em, capable o
inac i a ing ai bo ne i uses, can add ess his issue
i espec i e o he en ila ion quali y.
In a p e ious s udy, Fa -UVC scena io wi h 5 lamps
pe o ms subs an ially be e han e en a highe low
HEPA-based ai cleane . A po en ial ad an age o Fa -
UVC o e ai cleane s is ha i may no equi e “good”
ai mixing wi hin he oom (35).
Low-dose- a e a -UVC is a p omising ool o p e en
sp ead o ae osolized i uses in public loca ions.
Howe e , s ingen egula ions ega ding UVC
exposu e p esen signi ican challenges. Implemen ing
Fa -UVC echnology wi h UVC- esis an ex iles, as
u ilized in he Ini us-V sys em, appea s o be a iable
solu ion o in oducing his echnology in o public
spaces wi hou wai ing o long- e m human ial
esul s o egula o y changes (23).
The e we e no obse ed skin o eye changes due o 222
nm UVC exposu e in any pa icipan s du ing o a e
he p ocedu es in angiog aphy sui . Con a y o he
cu en echnique, UVC sys ems ope a ing a
wa eleng hs o 200-222 nm exhibi high eliabili y,
minimal heal h isks, ease o ins alla ion, and e ec i e
pe o mance wi hou eliance on consumables. By
in eg a ing his sys em wi h clo hes and co e s made
o UVC-p oo ab ic as u ilized in Ini us-V, we add ess
conce ns abou long- e m damage and enable sa e,
immedia e ope a ion unde UVC ligh . Ou p oposed
sys em includes UVC-p o ec ed wea able ab ics and
clo hing, pa ien and ope a ing oom co e s, UVC-
p oo glasses, and labo a o y ligh ing wi hin he 200-
222 nm ange.
Limi a ions
In ou s udy we did no wan o pe o m skin biopsy
examina ion p e and pos exposu e in s a o pa ien s
due o in asi e na u e o p ocedu e bu limi ed
assessmen by in ec ious disease, de ma ology and
oph halmology examina ions. Ou s udy was a
p elimina y sa e y s udy and en olled only angiog aphy
and s en pa ien s ins ead o highe isk in asi e
ca diological p ocedu es. P e and pos p ocedu e
mic obiologic cul u e examina ions we e no
pe o med.
S a emen o E hics
IRB in o ma ion: The p esen s udy was app o ed by
he Local E hics commi ee o A a u k Uni e si y
[2020/498]. All he s eps o his s udy was me he
s anda ds o Decla a ion o Helsinki and Good Clinical
P ac ice Guidelines.
In o med Consen
The w i en in o med consen o pa icipa e in he
s udy has been ob ained om all adul pa icipan s and
all ulne able pa icipan s' pa en /legal gua dian/nex
o kin.
Con lic o in e es s
The au ho s decla e ha he e is no con lic o in e es
ega ding he publica ion o his a icle.
Ini us-V sys em was de eloped by InnowayRG Inc and
Ves el Home appliances Inc. A pa en applica ion has
been made o TURKPATENT in he pa ne ship o hese
wo companies. (TR 2020/07546)
Ayhan Olcay, Se da Baki Albay ak, Onu Yolay a e
ounde s o InnowayRG Inc.
Mehme Cengiz Akbulbul and Mehme Ce in Baye a e
in en o s.
Mehme Fa uk Ak u k and Fadil Umihanić epo no
con lic s o in e es .
Financial Disclosu e
The au ho s ha e no decla ed inancial suppo .
WJMI, 5(1), 2025 - WORLD JOURNAL OF MEDICAL INNOVATIONS | A ailable a www.wo ldjmi.com
40
Au ho Con ibu ions
Ayhan Olcay con ibu ed o he s udy as design o
s udy, sample collec ion, c i ical analysis, ex w i ing
and his ologic examina ion and con ibu ed 25% each.
Se da Baki Albay ak con ibu ed o he s udy as design
o s udy and c i ical analysis and con ibu ed 15%.
İb ahim Fa uk Ak u k, Onu Yolay, Veda Oz u k, Ozgu
Yasa , Mehme Ka abay, He man Mayisoglu, Mehme
Ce in Baye , Mus a a Mazlum, Ceyhun Hazi oglu and
Fadil Umihanić con ibu ed o he s udy as sample
collec ion and ex w i ing and con ibu ed 6% each.
Da a A ailabili y S a emen
All da a gene a ed o analyzed du ing his s udy a e
included in his a icle. Fu he enqui ies can be
di ec ed o he co esponding au ho .
Re e ences
1. WHO. 2020 [A ailable om:
h ps://www.who.in /eme gencies/diseases/no el-
co ona i us-2019/si ua ion- epo s.
2. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, e al.
P esumed Asymp oma ic Ca ie T ansmission o
COVID-19. Jama. 2020;323(14):1406-7.
3. Kowalski W. Ul a iole ge micidal i adia ion
handbook: UVGI o ai and su ace disin ec ion:
Sp inge science & business media; 2010.
4. Budowsky EI, B esle SE, F iedman EA,
Zhelezno a NV. P inciples o selec i e inac i a ion o
i al genome. I. UV-induced inac i a ion o in luenza
i us. A ch Vi ol. 1981;68(3-4):239-47.
5. Nauno ic Z, Lim S, Bla chley ER, 3 d.
In es iga ion o mic obial inac i a ion e iciency o a
UV disin ec ion sys em employing an excime lamp.
Wa e Res. 2008;42(19):4838-46.
6. T e isan A, Pio esan S, Leona di A, Be occo M,
Nicolosi P, Pelizzo MG, e al. Unusual high exposu e o
ul a iole -C adia ion. Pho ochem Pho obiol.
2006;82(4):1077-9.
7. Za ina S, Camisa V, Lembo M, Vinci MR, Tucci
MG, Bo a M, e al. Acciden al exposu e o UV adia ion
p oduced by ge micidal lamp: case epo and isk
assessmen . Pho ochem Pho obiol. 2012;88(4):1001-4.
8. an Do emalen N, Bushmake T, Mo is DH,
Holb ook MG, Gamble A, Williamson BN, e al. Ae osol
and Su ace S abili y o SARS-CoV-2 as Compa ed wi h
SARS-CoV-1. N Engl J Med. 382. Uni ed S a es2020. p.
1564-7.
9. Se low RB, G is E, Thompson K, Woodhead
AD. Wa eleng hs e ec i e in induc ion o malignan
melanoma. P oc Na l Acad Sci U S A. 1993;90(14):6666-
70.
10. Balasub amanian D. Ul a iole adia ion and
ca a ac . J Ocul Pha macol The . 2000;16(3):285-97.
11. G een CF, Sca pino PV, Jensen P, Jensen NJ,
Gibbs SG. Disin ec ion o selec ed Aspe gillus spp. using
ul a iole ge micidal i adia ion. Can J Mic obiol.
2004;50(3):221-4.
12. Xu P, Kujundzic E, Peccia J, Scha e MP, Moss G,
He nandez M, e al. Impac o en i onmen al ac o s on
e icacy o uppe - oom ai ul a iole ge micidal
i adia ion o inac i a ing ai bo ne mycobac e ia.
En i on Sci Technol. 2005;39(24):9656-64.
13. Xu P, Peccia J, Fabian P, Ma yny JW, Fennelly
KP, He nandez M, e al. E icacy o ul a iole
ge micidal i adia ion o uppe - oom ai in inac i a ing
ai bo ne bac e ial spo es and mycobac e ia in ull-scale
s udies. A mosphe ic En i onmen . 2003;37(3):405-19.
14. Ko G, Fi s MW, Bu ge HA. The cha ac e iza ion
o uppe - oom ul a iole ge micidal i adia ion in
inac i a ing ai bo ne mic oo ganisms. En i on Heal h
Pe spec . 2002;110(1):95-101.
15. Pe kins JE, Bahlke AM, Sil e man HF. E ec o
ul a- iole i adia ion o class ooms on sp ead o
measels in la ge u al cen al schools. Am J Public
Heal h Na ions Heal h. 1947;37(5):529-37.
16. Dumyahn T, Fi s M. Cha ac e iza ion o
ul a iole uppe oom ai disin ec ion de ices.
Ame ican Indus ial Hygiene Associa ion Jou nal.
1999;60(2):219-27.
17. Jensen PA, Lambe LA, Iadema co MF, Ridzon
R. Guidelines o p e en ing he ansmission o
Mycobac e ium ube culosis in heal h-ca e se ings,
2005. MMWR Recomm Rep. 2005;54(R -17):1-141.
18. Na i a K, Asano K, Mo imo o Y, Iga ashi T,
Hamblin MR, Dai T, e al. Disin ec ion and healing
e ec s o 222-nm UVC ligh on me hicillin- esis an
S aphylococcus au eus in ec ion in mouse wounds. J
Pho ochem Pho obiol B. 2018;178:10-8.
19. Buonanno M, Rande s-Peh son G, Bigelow AW,
T i edi S, Lowy FD, Spo ni z HM, e al. 207-nm UV ligh
